Bekker, Linda-Gail http://orcid.org/0000-0002-0755-4386
Article History
First Online: 9 October 2023
Competing interests
: L.-G.B. has received honoraria for advisories unrelated to this commentary from Merck (Pty) Ltd, ViiV Healthcare and Gilead Sciences.